Clinical Trials Logo

Clinical Trial Summary

Purpose of study: This phase I/II trial is to evaluate the safety and feasibility of TCRαβ-depleted graft from haploidentical family donors in treating children and adolescents with malignant or non-malignant diseases.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02014506
Study type Interventional
Source Asan Medical Center
Contact Ho Joon Im, MD, PhD
Phone 82-2-3010-3371
Email hojim@amc.seoul.kr
Status Recruiting
Phase Phase 1/Phase 2
Start date January 2017
Completion date December 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05622032 - Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study
Recruiting NCT06041893 - Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide
Recruiting NCT06423131 - Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT N/A
Recruiting NCT05166967 - Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation Phase 4
Active, not recruiting NCT04778618 - Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation Phase 2
Completed NCT03236220 - Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation Phase 2
Recruiting NCT06381817 - Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients Phase 3